• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Saudis Seek Alternative Energy Partners Through WIPO Green Program

20/03/2019 by Intellectual Property Watch Leave a Comment

The government of oil-dependent Saudi Arabia has posted a series of requests for proposals for renewable energy technology partnerships via the World Intellectual Property Organization “Green” initiative that provides a marketplace for IP-protected products related to the environment.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Asia/Pacific, English, Environment, Human Rights, Patents/Designs/Trade Secrets, Regional Policy, WIPO

Chinese IP Officials Complete Study Of UK, European IP Law

06/03/2019 by Intellectual Property Watch Leave a Comment

A cohort of senior Chinese officials from the China National Intellectual Property Administration (CNIPA) has graduated from a four-month training programme at the Intellectual Property Research Institute of Queen Mary University of London.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Asia/Pacific, Copyright Policy, English, Europe, Finance, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains

Will US Drug Pricing Politics Change Intimidation Practices Globally?

05/03/2019 by Intellectual Property Watch 2 Comments

Fifa Rahman

Fifa Rahman writes: The global health world, particularly as concerns skyrocketing drug prices and patent abuse, is in a unique space in time. Recently, the Office of the United States Trade Representative (USTR) has been carrying on as per usual. It has threatened the Malaysian and Colombian governments at numerous junctures to prevent them from issuing compulsory licences – a completely legal mechanism which the US uses regularly – to access generic hepatitis C drugs. The Trump Administration has sent delegations to global health agencies in Geneva to intimidate them into reducing, or hiding, work on TRIPS flexibilities and fairer drug pricing.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, Bilateral/Regional Negotiations, English, Health & IP, Human Rights, North America, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

In Memoriam: Dilip Shah (1941-2019)

25/02/2019 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment

Dilip Shah was passionately committed to the twin causes of promoting fair access to medicines around the world, and to the success of the local Indian pharmaceutical industry. A bright light is out, writes Prof. Frederick Abbott.

Filed Under: IP Policies, Language, Themes, Venues, Asia/Pacific, English, Health & IP, Patents/Designs/Trade Secrets, Regional Policy

D G Shah, Founder Of Indian Pharmaceutical Alliance, Dies At Age 77: Economic Times

22/02/2019 by William New, Intellectual Property Watch 1 Comment

Dilip Shah, founder of the Indian Pharmaceutical Alliance (IPA) the organisation that represented the interests of Indian drug makers passed away in Mumbai on Friday. He was 77. Known in the industry as “DG”, Mr Shah started the IPA when the Indian pharma companies were trying to find their feet in the global pharma landscape that was dominated by the multinational pharma companies predominantly based out of Europe and USA. Shah who himself spent most of his career with the MNC drug companies …

Filed Under: IP Policies, Language, Themes, Venues, Asia/Pacific, Development, English, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy

ASEAN IP Offices Discuss Regional Trademark System

18/02/2019 by William New, Intellectual Property Watch Leave a Comment

The national intellectual property offices of the 10-member Association of Southeast Asian Nations (ASEAN) this week advanced work on developing a regional trademark registration system, according to European Union sources working with them.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Asia/Pacific, Development, English, Europe, Regional Policy, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains

Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive

13/02/2019 by William New, Intellectual Property Watch Leave a Comment

The government of Malaysia continues to face pressure from the United States pharmaceutical industry and potentially the US government to undo an action taken to make a key hepatitis C medicine more affordable in the country. Now Médecins Sans Frontières (MSF, Doctors Without Borders) has weighed in to defend the government’s right to use a patent flexibility in global trade law that allows them to take such actions on behalf of their citizens.

Filed Under: IP Policies, Themes, Venues, Asia/Pacific, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, WTO/TRIPS

Pre-Grant Opposition Filed Against Janssen’s Bedaquiline Fumarate Application In India

08/02/2019 by Intellectual Property Watch 2 Comments

Tuberculosis and its variant – Drug Resistant Tuberculosis (DR-TB) – are global public health emergencies. Current treatment regimens are expensive, tedious and prolonged: the overall treatment duration is 20 months or more, requiring daily administration of drugs that are more toxic and less effective than those used to treat drug-susceptible TB. Most of the drugs for treating TB are old and are known to have severe side-effects, writes Sandeep K. Rathod.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

Current R&D Causes High Prices In Drugs; New Model Needed To Make Drugs More Affordable, Speakers Say

01/02/2019 by Sinfah Tunsarawuth for Intellectual Property Watch Leave a Comment

BANGKOK – The current research and development model may encourage innovation in medicines, but has caused drugs to become unaffordable and inaccessible for people, particularly those in low- and middle-income countries, panellists and participants at a major conference here said.

Filed Under: IP Policies, Language, Themes, Venues, Asia/Pacific, Development, English, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Regional Policy

US Complaints About Technology Transfer In China: Negotiating The Endgame

24/01/2019 by Intellectual Property Watch 2 Comments

Dean Pinkert writes: The United States Trade Representative (USTR) has been open about its view of the difficulties faced by US companies who claim – generally anonymously – that they have been forced to transfer technology to Chinese entities: “The fact that China systematically implements its technology transfer regime in informal and indirect ways makes it ‘just as effective [as written requirements], but almost impossible to prosecute.’” As I explain in this article, I believe such informality is not merely a barrier to prosecutions; it also presents conceptual challenges for US trade negotiators as they attempt to craft effective means to address the concerns of US companies doing business in China.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, Bilateral/Regional Negotiations, Enforcement, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WTO/TRIPS

  • 1
  • 2
  • 3
  • …
  • 43
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting